BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23150986)

  • 1. Structure and glycolipid binding properties of the nematicidal protein Cry5B.
    Hui F; Scheib U; Hu Y; Sommer RJ; Aroian RV; Ghosh P
    Biochemistry; 2012 Dec; 51(49):9911-21. PubMed ID: 23150986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial pore-forming proteins as anthelmintics.
    Hu Y; Aroian RV
    Invert Neurosci; 2012 Jun; 12(1):37-41. PubMed ID: 22562659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.
    Wu CC; Hu Y; Miller M; Aroian RV; Sailor MJ
    ACS Nano; 2015 Jun; 9(6):6158-67. PubMed ID: 25950754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Caenorhabditis elegans glycolipid-binding galectin functions in host defense against bacterial infection.
    Ideo H; Fukushima K; Gengyo-Ando K; Mitani S; Dejima K; Nomura K; Yamashita K
    J Biol Chem; 2009 Sep; 284(39):26493-501. PubMed ID: 19635802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissimilar Crystal Proteins Cry5Ca1 and Cry5Da1 Synergistically Act against Meloidogyne incognita and Delay Cry5Ba-Based Nematode Resistance.
    Geng C; Liu Y; Li M; Tang Z; Muhammad S; Zheng J; Wan D; Peng D; Ruan L; Sun M
    Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28710264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nematode-specific cadherin CDH-8 acts as a receptor for Cry5B toxin in Caenorhabditis elegans.
    Peng D; Wan D; Cheng C; Ye X; Sun M
    Appl Microbiol Biotechnol; 2018 Apr; 102(8):3663-3673. PubMed ID: 29502179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from the Structure of an Active Form of
    Li J; Wang L; Kotaka M; Lee MM; Chan MK
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nematode (Ascaris suum) intestine is a location of synergistic anthelmintic effects of Cry5B and levamisole.
    Williams PDE; Brewer MT; Aroian RV; Robertson AP; Martin RJ
    PLoS Pathog; 2024 May; 20(5):e1011835. PubMed ID: 38758969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic and single-dose in vivo therapeutic studies of Cry5B anthelmintic action against hookworms.
    Hu Y; Zhan B; Keegan B; Yiu YY; Miller MM; Jones K; Aroian RV
    PLoS Negl Trop Dis; 2012; 6(11):e1900. PubMed ID: 23145203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance is non-futile: resistance to Cry5B in the nematode Caenorhabditis elegans.
    Barrows BD; Griffitts JS; Aroian RV
    J Invertebr Pathol; 2007 Jul; 95(3):198-200. PubMed ID: 17482642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacillus thuringiensis Cry6A exhibits nematicidal activity to Caenorhabditis elegans bre mutants and synergistic activity with Cry5B to C. elegans.
    Yu Z; Luo H; Xiong J; Zhou Q; Xia L; Sun M; Li L; Yu Z
    Lett Appl Microbiol; 2014 Jun; 58(6):511-9. PubMed ID: 24450432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.
    Hu Y; Miller MM; Derman AI; Ellis BL; Monnerat RG; Pogliano J; Aroian RV
    Appl Environ Microbiol; 2013 Sep; 79(18):5527-32. PubMed ID: 23835175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and Scalable Process to Produce Novel and Highly Bioactive Purified Cytosolic Crystals from Bacillus thuringiensis.
    Chicca J; Cazeault NR; Rus F; Abraham A; Garceau C; Li H; Atwa SM; Flanagan K; Soto ER; Morrison MS; Gazzola D; Hu Y; Liu DR; Nielsen MK; Urban JF; Ostroff GR; Aroian RV
    Microbiol Spectr; 2022 Aug; 10(4):e0235622. PubMed ID: 35946940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in mice.
    Hu Y; Georghiou SB; Kelleher AJ; Aroian RV
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e614. PubMed ID: 20209154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cry4B toxin of Bacillus thuringiensis subsp. israelensis kills Permethrin-resistant Anopheles gambiae, the principal vector of malaria.
    Ibrahim MA; Griko NB; Bulla LA
    Exp Biol Med (Maywood); 2013 Apr; 238(4):350-9. PubMed ID: 23760000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus thuringiensis Cry5B protein as a new pan-hookworm cure.
    Hu Y; Nguyen TT; Lee ACY; Urban JF; Miller MM; Zhan B; Koch DJ; Noon JB; Abraham A; Fujiwara RT; Bowman DD; Ostroff GR; Aroian RV
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):287-294. PubMed ID: 29772478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of receptor interaction in the mode of action of insecticidal Cry and Cyt toxins produced by Bacillus thuringiensis.
    Gómez I; Pardo-López L; Muñoz-Garay C; Fernandez LE; Pérez C; Sánchez J; Soberón M; Bravo A
    Peptides; 2007 Jan; 28(1):169-73. PubMed ID: 17145116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding between
    Wang Z; Fang L; Zhou Z; Pacheco S; Gómez I; Song F; Soberón M; Zhang J; Bravo A
    J Biol Chem; 2018 Jul; 293(29):11447-11458. PubMed ID: 29858245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic.
    Durmaz E; Hu Y; Aroian RV; Klaenhammer TR
    Appl Environ Microbiol; 2016 Feb; 82(4):1286-94. PubMed ID: 26682852
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Charuchaibovorn S; Sanprasert V; Sutthanont N; Hu Y; Abraham A; Ostroff GR; Aroian RV; Jaleta TG; Lok JB; Nuchprayoon S
    Am J Trop Med Hyg; 2019 Nov; 101(5):1177-1182. PubMed ID: 31516117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.